Altamira Therapeutics Ltd. (CYTOF)
OTCMKTS · Delayed Price · Currency is USD
0.0716
0.00 (0.00%)
At close: Sep 21, 2026
Altamira Therapeutics Market Cap
Altamira Therapeutics has a market cap or net worth of $409.23 thousand as of September 25, 2026. Its market cap has increased by 15.30% in one year.
Market Cap
409.23K
Enterprise Value
1.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.07
ChartMarket Cap Chart
Since August 8, 2014, Altamira Therapeutics's market cap has decreased from 171.70M to 409.23K, a decrease of -99.76%. That is a compound annual growth rate of -39.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 409.23K | -22.59% |
| Dec 31, 2025 | 528.62K | 40.64% |
| Dec 31, 2024 | 375.87K | -72.84% |
| Dec 29, 2023 | 1.38M | -75.59% |
| Dec 30, 2022 | 5.67M | -78.93% |
| Dec 31, 2021 | 26.91M | -10.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Agentix | 801.34K |
| Halberd | 747.30K |
| SQZ Biotechnologies Company | 707.79K |
| Orgenesis | 653.63K |
| Nextel Medical | 441.93K |
| Mosaic ImmunoEngineering | 441.77K |
| THC Farmaceuticals | 435.16K |
| Sorrento Therapeutics | 434.97K |